tiprankstipranks
Werewolf Therapeutics (HOWL)
NASDAQ:HOWL
US Market

Werewolf Therapeutics (HOWL) Income Statement

Compare
646 Followers

Werewolf Therapeutics Income Statement

Last quarter (Q3 2024), Werewolf Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Werewolf Therapeutics's net income was $-16.67M. See Werewolf Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 19.94M$ 16.40M$ 0.00$ 0.00$ 0.00
Gross Profit
$ -18.96M$ 13.89M$ -735.00K$ -777.00K$ -463.00K
Operating Expenses
$ 60.45M$ 72.46M$ 50.09M$ 22.40M$ 9.94M
Depreciation and Amortization
$ 1.76M$ 2.51M$ 735.00K$ 777.00K$ 463.00K
EBITDA
$ -32.47M$ -51.30M$ -49.25M$ -14.26M$ -9.41M
Operating Income
$ -40.50M$ -56.06M$ -50.09M$ -22.40M$ -9.94M
Other Income/Expenses
$ 3.13M$ 2.25M$ 104.00K$ 7.36M$ -312.00K
Pretax Income
$ -37.37M$ -53.81M$ -49.98M$ -15.04M$ -10.25M
Net Income
$ -37.37M$ -51.56M$ -49.77M$ -14.94M$ -10.99M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.05$ -1.79$ -1.82$ -0.52$ -0.38
Diluted EPS
$ -1.05$ -1.79$ -1.82$ -0.52$ -0.38
Weighted Average Shares Outstanding
35.65M 28.86M 27.31M 28.66M 28.66M
Weighted Average Shares Outstanding (Diluted)
35.65M 28.86M 27.31M 28.66M 28.66M
Currency in USD

Werewolf Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis